Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Capric Acid (Decanoic Acid).
Capric acid is a medium-chain fatty acid (C10:0) that acts as a non-competitive antagonist of AMPA receptors and a PPARγ agonist, primarily utilized for its ketogenic potential and anticonvulsant properties.
2969
172.26 g/mol
4.1
decanoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Capric Acid (Decanoic Acid) across standard consumer modalities.
The low melting point and potential for rancidity require high-quality sealing or enteric coating to prevent gastric irritation and 'burp-back'.
Incorporating high concentrations of capric acid can compromise the pectin matrix integrity, leading to oil leaching and a greasy mouthfeel.
The high dosage required for therapeutic efficacy typically exceeds the 20-30mg payload capacity of thin-film polymers, making this format impractical.
Ready to launch a product featuring Capric Acid (Decanoic Acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Capric Acid (Decanoic Acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Capric Acid (Decanoic Acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation